• Media
  • Careers
  • Contact Us
Portuguese (Brazil)Spanish
  • Acino in Latin America
    • Company Profile
    • Our Culture
    • Our Management
    • Our History
  • Services
    • We Partner
    • We Market
  • Products
  • We Care
  • Acino in Latin America
    • Company Profile
    • Our Culture
    • Our Management
    • Our History
  • Services
    • We Partner
    • We Market
  • Products
  • We Care
  • Media
  • Careers
  • Contact Us

Search

Utilizamos cookies para generar estadísticas que nos ayudan a mejorar la calidad de nuestro sitio web y su experiencia de usuario. Al hacer clic en «Aceptar todo», usted consiente el tratamiento de sus datos por parte de Acino y su transferencia a terceros. También puede personalizar su consentimiento para fines específicos de tratamiento de datos. Una vez que haya realizado su elección, haga clic en «Confirmar». Encontrará información detallada y podrá modificar sus preferencias en cualquier momento en nuestra Política de Privacidad .

Necessary Cookies Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics Cookies

We would like to set Google Analytics cookies to help us analyse the traffic on our website.

16.10.2026

Precautionary Recall of Berifen® 75 Mg IM in Ecuador

Recall Reference: Acino, part of Arcera is voluntarily recalling Berifen® 75 mg IM, with sanitary registration No. 2663-MEE-0417, lot 172380....

29.07.2026

Notice Regarding Theft of Medication July 29, 2026

To our customers, healthcare professionals, and the general public: Committed to safeguarding patient safety and maintaining the integrity of the...

22.06.2026

Market Announcement. Labeling Update.

Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda. (“M8”) hereby announces anupdate to the labeling of product packaging sold in...

25.05.2026

Market Announcement. NABOTA® Packaging Update.

Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda. (“M8”), responsible for the exclusive importation and commercialization of NABOTA® (botulinum toxin...

11.03.2026

Notice Regarding Theft of Medication March 23, 2025

Dear customers and healthcare professionals, our top priority is to ensure the quality, efficacy, and safety of those who use...

11.03.2026

Notice Regarding Theft of Medication May 18, 2025

Dear customers and healthcare professionals, our top priority is to ensure the quality, efficacy, and safety of those who use...

31.12.2025

Report on Transparency and Pay Equity Between Women and Men

13.11.2025

Notice of Registration Cancellation for the Drug Ultraproct LDO (fluocortolone pivalate, lidocaine hydrochloride)

In accordance with Resolution RDC No. 18/2014, issued by Anvisa (the Brazilian Health Regulatory Agency), Moksha8 Brasil Indústria e Comércio...

02.09.2025

Cargo Theft Alert: NABOTA® 100U – Lot X25025

Contact UsReport an Adverse Event
Acino - Part of Arcera
  • Acino in Latin America
  • Company Profile
  • Our Culture
  • Our Management
  • Our History
  • Services
  • We Partner
  • We Market
  • Products
  • We Care

  • Privacy
  • Terms of Use
  • Social Media Community Guidelines
Back to top

© 2026 Acino Latinoamericana S.A.

Este sitio web está dirigido a un público latinoamericano y ofrece información general sobre nuestros productos a un amplio abanico de consumidores. Es posible que parte del contenido no esté disponible o no sea aplicable en su país. Tenga en cuenta que no nos hacemos responsables de su acceso a dicho contenido. Para obtener información específica de su país, le recomendamos consultar con las autoridades reguladoras locales. Para cualquier consulta médica, consulte siempre con un profesional sanitario cualificado.